"/> Novus Biologicals™ Peptide bloquant d’anticorps BC… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps BCAS1

Réf. : BL-RE-104918Réf. fabricant : 18220366 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
8537
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77123. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 16 amino acids near the carboxy terminus of human BCAS1.

Points forts

Source

Synthetic

(Accession #: EAW75575) The BCAS1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-104918
Réf. fabricant18220366
Gene ID (Entrez)8537
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77123. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gènebreast carcinoma amplified sequence 1, breast carcinoma-amplified sequence 1, NABC1AIBC1Amplified and overexpressed in breast cancer, Novel amplified in breast cancer 1
Symbole de gène(s)BCAS1
Type de produitBCAS1
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne16 amino acids near the carboxy terminus of human BCAS1
Une question, une configuration particulière ?
Contactez-nous pour un devis.